News
Explore the latest news and material from across our business
7th Jan 2021
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
7th Jan 2021
The ALIVER Consortium announces positive results from Phase 2 equivalent trial of the novel liver dialysis device, Dialive™
7th Jan 2021
The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis
27th Aug 2020
Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE
